Literature DB >> 22102084

NF-κB p65 phosphorylated at serine-536 is an independent prognostic factor in Swedish colorectal cancer patients.

Andreas Lewander1, Jinfang Gao, John Carstensen, Gunnar Arbman, Hong Zhang, Xiao-Feng Sun.   

Abstract

INTRODUCTION: The NF-κB transcription factor protein family has diverse cellular and biological functions, and posttranslational modification is important to regulate these functions. An important site of phosphorylation of NF-κB p65 subunit is at serine-536 (phospho-Ser536-p65), and this phosphorylation is involved in regulation of transcriptional activity, nuclear localization, and protein stability. PATIENTS AND METHODS: In this study, we investigated expression of phospho-Ser536-p65 in colorectal cancers and its relationships with clinicopathological factors. The expression of phospho-Ser536-p65 was examined by immunohistochemistry in 203 primary colorectal cancers, 156 normal mucosa specimens, and 18 metastases in the lymph nodes.
RESULTS: The expression of phospho-Ser536-p65 increased from normal mucosa to primary tumor (p < 0.0001). Further, the increased expression of phospho-Ser536-p65 in the cytoplasm of the primary tumors correlated with worse survival of the patients independently of gender, age, tumor location, stage, and differentiation (p = 0.04; hazard ratio, 1.89; 95% CI 1.03-3.47).
CONCLUSION: The NF-κB p65 subunit phosphorylated at serine-536 is an independent prognostic factor in colorectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102084     DOI: 10.1007/s00384-011-1356-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  16 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma.

Authors:  J R Berenson; H M Ma; R Vescio
Journal:  Semin Oncol       Date:  2001-12       Impact factor: 4.929

3.  Nuclear factor-kappa B is upregulated in colorectal cancer.

Authors:  D S Lind; S N Hochwald; J Malaty; S Rekkas; P Hebig; G Mishra; L L Moldawer; E M Copeland; S Mackay
Journal:  Surgery       Date:  2001-08       Impact factor: 3.982

4.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.

Authors:  H Sakurai; H Chiba; H Miyoshi; T Sugita; W Toriumi
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

Review 5.  Targeted therapeutic agents for colorectal cancer.

Authors:  Cheng E Chee; Frank A Sinicrope
Journal:  Gastroenterol Clin North Am       Date:  2010-09       Impact factor: 3.806

6.  Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.

Authors:  Holger Buss; Anneke Dörrie; M Lienhard Schmitz; Elke Hoffmann; Klaus Resch; Michael Kracht
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

7.  Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis.

Authors:  Hong-Gang Yu; Liang-Liang Yu; Yanning Yang; He-Sheng Luo; Jie-Ping Yu; Juris J Meier; Henning Schrader; Andreas Bastian; Wolfgang E Schmidt; Frank Schmitz
Journal:  Oncology       Date:  2003       Impact factor: 2.935

Review 8.  The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.

Authors:  Yonghui Yu; Yu Wan; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

Review 9.  NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.

Authors:  X-F Sun; H Zhang
Journal:  Histol Histopathol       Date:  2007-12       Impact factor: 2.303

10.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Authors:  W Wang; J L Abbruzzese; D B Evans; L Larry; K R Cleary; P J Chiao
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  11 in total

1.  Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer.

Authors:  Arpit Saxena; Raja Fayad; Kamaljeet Kaur; Samantha Truman; Julian Greer; James A Carson; Anindya Chanda
Journal:  Cancer Biol Ther       Date:  2017-01-03       Impact factor: 4.742

2.  Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.

Authors:  Sun Hee Park; Philip Riley; Steven M Frisch
Journal:  Apoptosis       Date:  2013-08       Impact factor: 4.677

3.  Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines.

Authors:  Sebastian Gnosa; Yang-Mei Shen; Chao-Jie Wang; Hong Zhang; Johannes Stratmann; Gunnar Arbman; Xiao-Feng Sun
Journal:  J Transl Med       Date:  2012-05-29       Impact factor: 5.531

4.  Isoliensinine induces dephosphorylation of NF-kB p65 subunit at Ser536 via a PP2A-dependent mechanism in hepatocellular carcinoma cells: roles of impairing PP2A/I2PP2A interaction.

Authors:  Guangwen Shu; Lang Zhang; Shanqing Jiang; Zhuo Cheng; Guan Wang; Xu Huang; Xinzhou Yang
Journal:  Oncotarget       Date:  2016-06-28

5.  STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.

Authors:  Xi Pan; Binyuan Jiang; Jianhao Liu; Juan Ding; Yuehui Li; Ruili Sun; Li Peng; Changfei Qin; Shujuan Fang; Guancheng Li
Journal:  Oncotarget       Date:  2017-07-11

6.  A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion.

Authors:  Jiyeon Yoon; Sung Jin Cho; Young San Ko; Jinju Park; Dong Hoon Shin; In Chan Hwang; Sang Yeun Han; Seon Young Nam; Min A Kim; Mee Soo Chang; Hye Seung Lee; Woo Ho Kim; Byung Lan Lee
Journal:  BMC Gastroenterol       Date:  2013-02-12       Impact factor: 3.067

7.  PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase.

Authors:  Nitin Kumar Agarwal; Xiaoping Zhu; Mihai Gagea; Charles L White; Gilbert Cote; Maria-Magdalena Georgescu
Journal:  Oncotarget       Date:  2014-02-15

8.  Photoreceptor Cells Produce Inflammatory Mediators That Contribute to Endothelial Cell Death in Diabetes.

Authors:  Deoye Tonade; Haitao Liu; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-08-01       Impact factor: 4.799

9.  Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis.

Authors:  Xiaowen Ge; Yiqun Du; Jianfeng Chen; Na Zhu; Jiamei Yao; Xin Zhang; Na Wang; Yujing Sun; Feng Gao; Weiguo Hu; Yingyong Hou
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244

Review 10.  NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.

Authors:  Dang Wu; Pin Wu; Lufeng Zhao; Lijian Huang; Zhigang Zhang; Shuai Zhao; Jian Huang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.